Skip to content

DR. PIERRETTE MICHEL

Active
Private limited companyfounded 2002active for 24 yearsGemeentestraat 229, 3010 Leuven, BelgiumKBO/BCE: BE 0477.918.802
Summary

DR. PIERRETTE MICHEL has been active since 2002 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €777,451 and a net result of €132,069. Equity remains stable across the filed financial years (±1.6% per year). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
“De uitoefening van de geneeskunde door de geneesheer-aandeelhouder specialisatie anatomo-pathologie,in naam en voor rekening…” (deed in Dutch)
From the articles, 8 activitiesNo NACE code in the KBO yet
Size
€790,389total assets 2025
Equity
€777,451
Profit
€132,069
Turnover not published (micro format)
Financial health
96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
Accounts 5 days early1 of 3 deeds read
Why 96raises riskNo registered site in the KBOLiquidity: current ratio 80.25, cash €65,524, halvedlowers riskSize: total assets €790,389Equity €777,451 (98.4% of total assets)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 72% of its sector peers (no NACE code, micro)
Financial strength · tick = 2024
Strong
Solvency 100=
equity 98.4% of total assets
Liquidity 60-10
short-term debt 1.2% · cash 8.3%
Profitability 90-1
return on assets 16.7%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: 0.1%▲ +0.1 percentage points vs 12-2024 02-2025: < 0.1%▼ -0.1 percentage points vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: 0.1%▲ +0.1 percentage points vs 12-2025highest value 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €70,000 on 30-day terms is acceptable
Liquidity ample (current ratio 80.25, compared with 6.12 in 2024, above the usual 1.5; short-term debt: 1.2% and cash: 8.3% of total assets), and 1.6% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro): better than 81% on solvency, 57% on liquidity, 72% on profitability and 77% on growth.

The bankruptcy probability was computed on 21-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €790,389
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Equity €777,451 (98.4% of total assets)
NBB · annual accounts
raises risk · No registered site in the KBO
KBO · seat and establishments
raises risk · Liquidity: current ratio 80.25, cash €65,524, halved
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
19202122232425
2019 to 2025 · latest year €777,451
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 26-01-2026, 5 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
5 days early
2024
15 days early
2023
1 day early
2022
4 days early
2021
17 days early
2020
33 days early
2019
18 days early
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its last 7 accounts on average 13 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 26 January (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end22-10-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Liquidity more than 13 timescurrent ratio 80.25
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 7 profitable years in a rowprofit 2025: €132,069 7 years View
  • One director decidessole director in office 1 View

By topic

Financials

Financial year
2025
Total assets
€790,389
Profit
€132,069
Solvency
98.4%
Total assets▲ 2.0%
Net result
20192025
Go to Financials

Timeline

Events
27
Since
2004
Next accounts
by 31-01-2027
  1. 30-06-2024Highest result from 2019 to 2025
  2. 05-04-2024Resignation: MICHEL Pierrette (director)
  3. 30-01-2024Annual accounts filed
Go to Timeline

Company details

Legal form
Private limited company
Founded
05-07-2002
Year ends
30-06
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
30
Annual meeting
Fourth Friday of November at 20:00
Purpose
“De uitoefening van de geneeskunde door de geneesheer-aandeelhouder specialisatie…” (deed in Dutch)
Go to Articles of association

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.